
Tri Medix Pharma Private Limited
Pharmaceutical company manufacturing tablets, capsules, and injections, offering contract manufacturing and franchise opportunities.
Pharmaceutical company manufacturing tablets, capsules, and injections, offering contract manufacturing and franchise opportunities.
Tri Medix Pharma Private Limited (TMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2007 and has a history of 17 years and 11 months. Its registered office is in Chandigarh, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.76 M.
Jagmohan Singh, Ravinder Kumar, and Manohar Lal serve as directors at the Company.
+91-XXXXXXXXXX
U24232CH2007PTC030772
030772
Private Limited Indian Non-Government Company
12 Apr 2007
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chandigarh
Tri Medix Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Vitamin Tablets & Capsules, Vitamin D3 Tablets & Capsules.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jagmohan Singh ![]() | Director | 12-Apr-2007 | Current |
Ravinder Kumar ![]() | Director | 12-Apr-2007 | Current |
Manohar Lal ![]() | Director | 12-Apr-2007 | Current |
Tri Medix Pharma Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.36% decrease. The company also saw a substantial improvement in profitability, with a 34.46% increase in profit. The company's net worth Soared by an impressive increase of 21.28%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Tri Medix Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹1.76 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
05 Mar 2013 | State Bank Of India | ₹1.50 M | Open |
18 Oct 2011 | Religare Finvest Limited | ₹0.26 M | Open |
Tri Medix Pharma has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Tri Medix Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tri Medix Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Tri Medix Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Tri Medix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
A charge with State Bank Of India amounted to Rs. 1.50 M with Charge ID 10419571 was registered on 05 Mar 2013.
A charge with Religare Finvest Limited amounted to Rs. 0.26 M with Charge ID 10313159 was registered on 18 Oct 2011.
Jagmohan Singh was appointed as a Director was appointed as a Director on 12 Apr 2007 & has been associated with this company since 17 years 11 months .
Ravinder Kumar was appointed as a Director was appointed as a Director on 12 Apr 2007 & has been associated with this company since 17 years 11 months .
Tri Medix Pharma Private Limited was incorporated on 12 Apr 2007.
The authorized share capital of Tri Medix Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Tri Medix Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Tri Medix Pharma Private Limited is House No: 3203 Sector 35-D India, Chandigarh, 160035.
The corporate identification number (CIN) of Tri Medix Pharma Private Limited is U24232CH2007PTC030772 and the company number is 030772 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Tri Medix Pharma Private Limited has fallen by -3.36%.
As Per 2019 financial reports, 10 employees are currently employed by Tri Medix Pharma Private Limited.
The financial reports for the fiscal year 2019 indicates that The net worth of Tri Medix Pharma Private Limited has experienced an upsurge of 21.28%.
As per the financial statements for fiscal Year 2019, The total open charges for Tri Medix Pharma Private Limited amount to ₹ 1.76 M.
The most recent Balance Sheet for Tri Medix Pharma Private Limited was filed with the ROC on 31 Mar 2024.